These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1544124)

  • 21. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
    Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
    Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumors of the neuroblastoma group.
    Shimada H
    Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
    Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
    Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology Group.
    Joshi VV; Silverman JF; Altshuler G; Cantor AB; Larkin EW; Neill JS; Norris HT; Shuster JJ; Holbrook CT; Hayes FA
    Hum Pathol; 1993 May; 24(5):493-504. PubMed ID: 8491489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma.
    Kubota M; Suita S; Tajiri T; Shono K; Fujii Y
    J Pediatr Surg; 2000 Jan; 35(1):92-5. PubMed ID: 10646782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic neuroblastoma with ganglioneuromatous differentiation and mandibular involvement.
    Bhattacharyya I; Williamson A; Cohen DM; Bever JL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Nov; 88(5):586-92. PubMed ID: 10556754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
    Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
    Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
    Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
    J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
    Munchar MJ; Sharifah NA; Jamal R; Looi LM
    Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
    George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group.
    Chatten J; Shimada H; Sather HN; Wong KY; Siegel SE; Hammond GD
    Hum Pathol; 1988 Oct; 19(10):1187-98. PubMed ID: 3169728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
    Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
    Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [N-myc oncogene amplification in tumors of the sympathetic nervous system: preliminary study of methods and clinico-pathologic correlations].
    Dahbiová R; Kodet R; Soukup J; Kavan P; Smelhaus V; Koutecký J
    Cesk Patol; 1997 Aug; 33(3):83-8. PubMed ID: 9471397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group.
    Joshi VV; Chatten J; Sather HN; Shimada H
    Mod Pathol; 1991 Mar; 4(2):139-47. PubMed ID: 2047378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
    Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.